INTRAVENOUS VITAMIN C
The use of vitamin C as an adjunctive cancer treatment is not new. In the 1970s, two-time Nobel prize winner and molecular biologist Dr. Linus Pauling in conjunction with Dr. Ewing Cameron and Dr. Allan Campbell published several papers that showed beneficial effects
of high dose vitamin C, given by a combination of intravenous and oral routes, in one hundred patients with terminal cancer deemed to be untreatable by conventional methods. In comparison with patients not receiving vitamin C, patients treated with vitamin C had improved symptoms and increased survival times that were 3-20 times greater. (Read one of the original papers here).
Subsequent studies from the Mayo Clinic could not repeat these results so the role of vitamin C in cancer treatment was dismissed by oncologists. However, the Mayo studies used oral vitamin C, and Cameron and Pauling used intravenous vitamin C. Since this time, much research has proven the benefits of intravenous vitamin C as an adjunctive therapy in cancer treatment. See below for some relevant research papers.
WILL ORAL VITAMIN C HAVE THE SAME EFFECTS?
Absorption of vitamin C via the oral route is tightly controlled by the gastrointestinal tract. At doses greater than 2g, less than 20% is absorbed and any not absorbed attracts water, resulting in abdominal discomfort and diarrhea. Intravenous vitamin C bypasses this gastrointestinal control mechanism and is the only route that allows for blood levels high enough for vitamin C's beneficial effects for cancer treatment. See research here.
HOW DOES INTRAVENOUS VITAMIN C WORK?
Vitamin C has several mechanisms of action against cancer. One of the most studied mechanisms shows that intravenous vitamin C kills cancer cells by acting as a pro-oxidant via the formation of hydrogen peroxide, but leaves healthy cells intact. Cancer cells lack sufficient enzymes to break down the hydrogen peroxide, which builds up and causes cancer cell death. See relevant research papers here and here.
Subsequent studies from the Mayo Clinic could not repeat these results so the role of vitamin C in cancer treatment was dismissed by oncologists. However, the Mayo studies used oral vitamin C, and Cameron and Pauling used intravenous vitamin C. Since this time, much research has proven the benefits of intravenous vitamin C as an adjunctive therapy in cancer treatment. See below for some relevant research papers.
WILL ORAL VITAMIN C HAVE THE SAME EFFECTS?
Absorption of vitamin C via the oral route is tightly controlled by the gastrointestinal tract. At doses greater than 2g, less than 20% is absorbed and any not absorbed attracts water, resulting in abdominal discomfort and diarrhea. Intravenous vitamin C bypasses this gastrointestinal control mechanism and is the only route that allows for blood levels high enough for vitamin C's beneficial effects for cancer treatment. See research here.
HOW DOES INTRAVENOUS VITAMIN C WORK?
Vitamin C has several mechanisms of action against cancer. One of the most studied mechanisms shows that intravenous vitamin C kills cancer cells by acting as a pro-oxidant via the formation of hydrogen peroxide, but leaves healthy cells intact. Cancer cells lack sufficient enzymes to break down the hydrogen peroxide, which builds up and causes cancer cell death. See relevant research papers here and here.
| breast_ca__ivc.pdf |
| cancer__ivc.pdf |
| ovarian_cancer__ivc.pdf |
| quality_of_life_and_ivc.pdf |
| inflammation__tumour_markers__ivc.pdf |
| safety__ivc.pdf |
